JP2023503330A5 - - Google Patents

Info

Publication number
JP2023503330A5
JP2023503330A5 JP2022530211A JP2022530211A JP2023503330A5 JP 2023503330 A5 JP2023503330 A5 JP 2023503330A5 JP 2022530211 A JP2022530211 A JP 2022530211A JP 2022530211 A JP2022530211 A JP 2022530211A JP 2023503330 A5 JP2023503330 A5 JP 2023503330A5
Authority
JP
Japan
Prior art keywords
alkyl
dimethylocta
dien
dihydroxy
pentylbenzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022530211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503330A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051608 external-priority patent/WO2021102568A1/en
Publication of JP2023503330A publication Critical patent/JP2023503330A/ja
Publication of JP2023503330A5 publication Critical patent/JP2023503330A5/ja
Pending legal-status Critical Current

Links

JP2022530211A 2019-11-26 2020-11-25 カンナビノイド誘導体 Pending JP2023503330A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962940549P 2019-11-26 2019-11-26
US62/940,549 2019-11-26
US202063104866P 2020-10-23 2020-10-23
US63/104,866 2020-10-23
US202063112999P 2020-11-12 2020-11-12
US63/112,999 2020-11-12
PCT/CA2020/051608 WO2021102568A1 (en) 2019-11-26 2020-11-25 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2023503330A JP2023503330A (ja) 2023-01-27
JP2023503330A5 true JP2023503330A5 (enExample) 2023-11-22

Family

ID=76128609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022530211A Pending JP2023503330A (ja) 2019-11-26 2020-11-25 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20230286906A1 (enExample)
EP (1) EP4065549B1 (enExample)
JP (1) JP2023503330A (enExample)
WO (1) WO2021102568A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP4065568A4 (en) * 2019-11-26 2024-01-03 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CN114507153B (zh) * 2020-11-17 2025-06-24 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
CN115260053B (zh) * 2022-08-09 2023-11-28 中国海洋大学 一种具有抗肿瘤活性的化合物及其制备方法与它的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589245B2 (ja) * 1992-01-14 1997-03-12 財団法人生産開発科学研究所 Ｎ−（３−アルキル（またはアルケニル）−４−ヒドロキシベンゾイル）グリシン亜鉛錯体
JP3162953B2 (ja) * 1995-06-07 2001-05-08 株式会社資生堂 ピラゾリジン誘導体及びラジカルスカベンジャー、虚血再潅流障害抑制剤
US8481085B2 (en) * 2006-06-15 2013-07-09 Gw Pharma Limited Pharmaceutical compositions comprising cannabigerol
RU2010136954A (ru) * 2008-02-06 2012-03-20 Носсира С.А. (Es) Фенилпрениловые производные морского и синтетического происхождения для лечения нарушения познавательной способности, нейродегенеративных или нервных заболеваний или нарушений
CN105030750B (zh) * 2011-12-23 2018-08-28 中国医学科学院医药生物技术研究所 一组木豆素结构类似化合物在抗丙肝病毒和抗艾滋病毒的应用
GB2511470B (en) * 2012-04-25 2020-07-15 Univ Sussex Treatment of fungal infections using alternative oxidase inhibitors
WO2017175064A1 (en) * 2016-04-04 2017-10-12 Full Spectrum Laboratories Ltd Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
CN111170884B (zh) * 2018-11-09 2023-05-09 四川大学 一类水杨酰胺类化合物、其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2023503330A5 (enExample)
JP2022551067A5 (enExample)
JP2022540434A5 (enExample)
JP2022551066A5 (enExample)
JP2023503601A5 (enExample)
JP7747712B2 (ja) 活性物質の送達のための生分解性脂質
JP2022540432A5 (enExample)
JP2013538198A5 (enExample)
ES2461967T3 (es) Compuestos de pirrolo[2,3-d]pirimidina
CN1993346B (zh) 噻吩化合物
JP2023503331A5 (enExample)
ES2791186T3 (es) Triazoles como inhibidores de receptores NR2B
JP2022539401A5 (enExample)
ES2590929T3 (es) Derivados de bencilsulfonamida útiles como inhibidores de MOGAT-2
SK133698A3 (en) Process to prepare oxazolidinones
ES2791252T3 (es) Pirazoles
RU2012120387A (ru) Замещенные производные 4-аминоциклогексана
JP2022540586A5 (enExample)
US6630509B2 (en) Phenalkyloxy-phenyl derivatives
EA009881B1 (ru) Производные n-пирролидин-3-ил-амида в качестве ингибиторов обратного захвата серотонина и норадреналина
RU2009142431A (ru) Производные триазолопиридинкарбоксамидов и триазолопиримидинкарбоксамидов, их получение и их применение в терапии
PH12015501697B1 (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
CA2716961A1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
IL287159B1 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
JP2010513434A5 (enExample)